U.S. stocks closed another record-setting week with a muted performance Friday, as hope built on Wall Street that the U.S. economy can manage the rare feat of suppressing high inflation without ...
The Dow Jones Industrial Average edged up to another record high while declines in tech stocks pulled other indexes lower.
The blue-chip Dow Jones Industrial Average closed at a record high as a subdued inflation report stoked hopes for more ...
A medicine that sidesteps the brain's dopamine receptors to reach different targets represents a new approach to ...
The Dow Jones Industrial Average closed at a record high, driven by investor optimism following a subdued inflation report.
Bristol Myers trades higher after the FDA approves an oral medication for schizophrenia in adults, fiscal fourth-quarter ...
Studies showed Bristol Myers Squibb's drug, KarXT, improved symptoms of schizophrenia and led to fewer side effects than existing antipsychotic treatments. Researchers are optimistic patients might ...
The Dow jumped more than 400 points Friday to an all-time high after a benign inflation report cleared the way for the ...
British scientists have hailed the US approval of a new drug for schizophrenia, saying it “has the potential to change the ...
U.S. stock indexes are drifting around their records Friday as hopes hold that the economy can pull off the rare feat of ...
The agency is considering whether to limit the indications of Keytruda, Opdivo, and Tevimbra to PD-L1-positive patients amid testing uncertainties.
Experts expressed enthusiasm Friday after US health regulators approved the first new form of treatment for schizophrenia in decades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback